This session addresses 3 controversial topics; Statin use, PPI use, and Alzheimer’s Disease agent use in elderly LTC patients. The following questions will be addressed: Are high dose statins necessary in the elderly? Do PPI's pose any problems, especially with long term use? What should be considered in long term use of PPIs? Is there enough data to support the use of Alzheimer Disease agents currently available and the duration of their use? The format will be an exciting point-counter point debate of these controversial issues in long term care medicine and pharmacy. For each topic, there will be a brief didactic presentation setting up the issues and controversies followed by a crossfire-like debate between panelists representing the pro and con for the topic.
Summarize the evidence for and against intensive lipid lowering therapy in the elderly LTC population
Discuss the evidence for and against long term PPI therapy for various indications in the elderly LTC population
Summarize the evidence for and against the use of the currently available Alzheimer's Disease agents in the elderly LTC population